381 related articles for article (PubMed ID: 27112208)
21. Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
Altorki N; Schwartz GK; Blundell M; Davis BM; Kelsen DP; Albino AP
Cancer; 1993 Aug; 72(3):649-57. PubMed ID: 8334620
[TBL] [Abstract][Full Text] [Related]
22. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach.
Park J; Schulz S; Haaf J; Kairys JC; Waldman SA
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):739-44. PubMed ID: 12163327
[TBL] [Abstract][Full Text] [Related]
23. Allelic imbalance on distal 7q (7q36.1-q36.3) in gastric cardia and oesophageal (Barrett's) adenocarcinoma.
Vissers KJ; Dinjens WN; Riegman PH; Tilanus HW; van Dekken H
Anticancer Res; 2005; 25(2A):913-6. PubMed ID: 15868927
[TBL] [Abstract][Full Text] [Related]
24. Pathology of upper gastrointestinal malignancies.
Sarbia M; Becker KF; Höfler H
Semin Oncol; 2004 Aug; 31(4):465-75. PubMed ID: 15297939
[TBL] [Abstract][Full Text] [Related]
25. A cancer staging primer: esophagus and esophagogastric junction.
Rice TW; Blackstone EH; Rusch VW
J Thorac Cardiovasc Surg; 2010 Mar; 139(3):527-9. PubMed ID: 20176201
[No Abstract] [Full Text] [Related]
26. Adenocarcinoma of the esophago-gastric junction.
Siewert JR; Stein HJ; Feith M
Scand J Surg; 2006; 95(4):260-9. PubMed ID: 17249275
[TBL] [Abstract][Full Text] [Related]
27. Histopathologic classification of adenocarcinoma of the esophagogastric junction.
Baldus SE
Recent Results Cancer Res; 2010; 182():29-38. PubMed ID: 20676869
[No Abstract] [Full Text] [Related]
28. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.
Siewert JR; Feith M; Stein HJ
J Surg Oncol; 2005 Jun; 90(3):139-46; discussion 146. PubMed ID: 15895452
[TBL] [Abstract][Full Text] [Related]
29. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M
Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359
[TBL] [Abstract][Full Text] [Related]
30. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract][Full Text] [Related]
31. Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions.
Bornschein J; Dingwerth A; Selgrad M; Venerito M; Stuebs P; Frauenschlaeger K; Achilleos A; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 2015 May; 27(5):492-500. PubMed ID: 25822856
[TBL] [Abstract][Full Text] [Related]
32. Involvement of cancer-activating genes on chromosomes 7 and 8 in esophageal (Barrett's) and gastric cardia adenocarcinoma.
Vissers KJ; Riegman PH; Alers JC; Tilanus HW; van Dekken H
Anticancer Res; 2001; 21(6A):3813-20. PubMed ID: 11911252
[TBL] [Abstract][Full Text] [Related]
33. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group.
Wijnhoven BP; Siersema PD; Hop WC; van Dekken H; Tilanus HW
Br J Surg; 1999 Apr; 86(4):529-35. PubMed ID: 10215831
[TBL] [Abstract][Full Text] [Related]
34. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site.
Crane SJ; Richard Locke G; Harmsen WS; Diehl NN; Zinsmeister AR; Joseph Melton L; Romero Y; Talley NJ
Aliment Pharmacol Ther; 2007 Feb; 25(4):447-53. PubMed ID: 17270000
[TBL] [Abstract][Full Text] [Related]
35. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression.
Kastelein F; van Olphen SH; Steyerberg EW; Spaander MC; Bruno MJ;
Gut; 2016 Apr; 65(4):548-54. PubMed ID: 25903690
[TBL] [Abstract][Full Text] [Related]
36. Clonality analysis of synchronous gastro-oesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing.
Xing X; Jia S; Wu J; Feng Q; Dong B; Li B; Jia Y; Shan F; Li Y; Zhang Y; Hu Y; Wang X; Liu X; Yu W; Zhang L; Bu Z; Wu A; Li Z; Ji J
J Pathol; 2017 Oct; 243(2):165-175. PubMed ID: 28671728
[TBL] [Abstract][Full Text] [Related]
37. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
Zhang XH; Wang QZ
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
[No Abstract] [Full Text] [Related]
38. Next-generation Sequencing in the Management of Gastric and Esophageal Cancers.
Rubinstein JC; Nicolson NG; Ahuja N
Surg Clin North Am; 2019 Jun; 99(3):511-527. PubMed ID: 31047039
[TBL] [Abstract][Full Text] [Related]
39. [Controversy on classification of cancers of the gastro-esophageal junction and its clinical significance].
Zhang X
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):76. PubMed ID: 16737630
[No Abstract] [Full Text] [Related]
40. Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas.
Stocks SC; Pratt N; Sales M; Johnston DA; Thompson AM; Carey FA; Kernohan NM
Genes Chromosomes Cancer; 2001 Sep; 32(1):50-8. PubMed ID: 11477661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
